Chronic Schizophrenia Clinical Trial
Official title:
Integrated Psychological Therapy (IPT) + Emotional Management Therapy (EMT) in Chronic Schizophrenia: Study Protocol for a Randomized Controlled Trial
Background: The chronic phase of schizophrenia (CS) that extremely affects the way people
think, feel and act, underlines the need for effective interventions in patients affected by
this disorder. The Integrated Psychological Therapy appears in clinical practice guidelines
as the reference therapy in the treatment of this type of patients. In this paper authors
propose to include in this program a new module focused on Emotional Management Therapy in
order to reinforce its effectiveness. The aim of this study is to describe the design of a
study protocol for a randomized controlled trial in which the objective is to assess the
efficacy of this modified IPT program in patients with CS compared to treatment as usual
(pharmacological treatment and social and leisure activities in a Day Care Center).
Methods/design: This is a randomized study with pre and post-treatment assessment and with a
6- and 12-month follow-up. Patients are to be randomly assigned to one of two treatments: (1)
a experimental group: integrated psychological therapy in conjunction with emotional
management therapy (IPT+EMT), composed of 2-hour biweekly 60 group sessions for 32 weeks, in
addition to the treatment as usual (TAU), or (2) a control group (treatment as usual).
Participants in both groups will be evaluated at baseline (pre-treatment) and at
post-treatment after 8 months. The primary outcome will be that patients in the experimental
group will show a greater improvement over participants in the control group in reducing
symptoms and increasing emotional abilities, as well as in improving their quality of life.
The secondary outcome will be that these results will maintain at the 6- and 12-month
follow-up in the experimental group.
Background: The chronic phase of schizophrenia (CS) that extremely affects the way people
think, feel and act, underlines the need for effective interventions in patients affected by
this disorder. The Integrated Psychological Therapy (IPT) appears in clinical practice
guidelines as the reference therapy in the treatment of this type of patients. In this paper
authors propose to include in this program a new module focused on Emotional Management
Therapy (EMT) in order to reinforce its effectiveness. The aim of this study is to describe
the design of a study protocol for a randomized controlled trial in which the objective is to
assess the efficacy of this modified IPT program in patients with CS compared to treatment as
usual (pharmacological treatment and social and leisure activities in a Day Care Center).
Methods/design: This is a randomized study with pre and post-treatment assessment and with a
6- and 12-month follow-up. Patients are to be randomly assigned to one of two treatments: (1)
a experimental group: integrated psychological therapy in conjunction with emotional
management therapy (IPT+EMT), composed of 2-hour biweekly 60 group sessions for 32 weeks, in
addition to the treatment as usual (TAU), or (2) a control group (treatment as usual).
Participants in both groups will be evaluated at baseline (pre-treatment) and at
post-treatment after 8 months. The primary outcome will be that patients in the experimental
group will show a greater improvement over participants in the control group in reducing
symptoms and increasing emotional abilities, as well as in improving their quality of life.
The secondary outcome will be that these results will maintain at the 6- and 12-month
follow-up in the experimental group.
Discussion: This study provides the description of a clinical trial based on specific
psychological intervention (IPT+EMT) for patients with chronic schizophrenia, aiming to
improve lasting clinical and functional outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00161044 -
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
|
N/A | |
Completed |
NCT01450514 -
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT05809882 -
Study of Experience of High-frequency Repetitive Transcranial
|
N/A | |
Recruiting |
NCT05948696 -
Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia
|
||
Completed |
NCT06206798 -
Resourcefulness Group Intervention on Recovery and Quality of Life
|
N/A | |
Completed |
NCT01761383 -
Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia
|
N/A | |
Completed |
NCT01891929 -
Cognitive Remediation and Sheltered Employment in Schizophrenia
|
N/A | |
Completed |
NCT02298985 -
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
|
Phase 4 | |
Recruiting |
NCT00525863 -
Oxygen Therapy in Schizophrenia
|
Phase 3 | |
Completed |
NCT02624167 -
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT00789698 -
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
|
Phase 3 | |
Recruiting |
NCT06349369 -
Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia
|
N/A | |
Completed |
NCT02421146 -
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study
|
N/A | |
Active, not recruiting |
NCT00664274 -
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
|
N/A | |
Terminated |
NCT00148616 -
Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
|
Phase 3 |